BioNTech SE (ETR:22UA)
Germany · Delayed Price · Currency is EUR 101.70
+6.60 (6.94%)
At close: Aug 21, 2026
BioNTech SE Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 25,084 | 19,497 | 26,387 | 22,698 | 34,159 | 54,749 | |
Market Cap Growth | 9.32% | -26.11% | 16.25% | -33.55% | -37.61% | 241.19% |
Enterprise Value | 12,217 | 5,383 | 8,655 | 7,810 | 22,089 | 52,601 |
Last Close Price | 101.70 | 81.35 | 108.70 | 95.02 | 143.00 | 212.24 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 24.40 | 3.62 | 5.32 |
PS Ratio | 9.47 | 6.79 | 9.59 | 5.94 | 1.97 | 2.89 |
PB Ratio | 1.41 | 1.01 | 1.36 | 1.12 | 1.70 | 4.60 |
P/TBV Ratio | 1.57 | 1.13 | 1.45 | 1.19 | 1.72 | 4.68 |
P/FCF Ratio | 53.46 | 69.41 | - | 4.43 | 2.58 | 71.83 |
P/OCF Ratio | 36.90 | 42.76 | 127.04 | 4.23 | 2.52 | 61.54 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 4.71 | 1.88 | 3.15 | 2.05 | 1.28 | 2.77 |
EV/EBITDA Ratio | - | - | - | 7.04 | 1.84 | 3.53 |
EV/EBIT Ratio | - | - | - | 8.04 | 1.85 | 3.54 |
EV/FCF Ratio | 26.04 | 19.17 | - | 1.53 | 1.67 | 69.01 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 |
Debt / EBITDA Ratio | - | - | - | 0.19 | 0.02 | 0.02 |
Debt / FCF Ratio | 0.67 | 0.95 | - | 0.04 | 0.02 | 0.40 |
Net Debt / Equity Ratio | -0.74 | -0.70 | -0.80 | -0.81 | -0.69 | -0.15 |
Net Debt / EBITDA Ratio | 9.52 | 11.99 | 13.27 | -14.71 | -1.16 | -0.12 |
Net Debt / FCF Ratio | -28.02 | -47.96 | 197.84 | -3.19 | -1.05 | -2.33 |
Asset Turnover | 0.13 | 0.13 | 0.12 | 0.17 | 0.89 | 2.09 |
Inventory Turnover | 3.74 | 3.10 | 1.69 | 1.51 | 6.36 | 10.28 |
Quick Ratio | 7.03 | 6.87 | 6.88 | 9.12 | 7.19 | 4.15 |
Current Ratio | 7.85 | 7.54 | 7.45 | 9.43 | 7.43 | 4.33 |
Return on Equity (ROE) | -9.30% | -5.88% | -3.36% | 4.62% | 59.06% | 155.18% |
Return on Assets (ROA) | -5.41% | -3.56% | -3.53% | 2.62% | 38.09% | 102.25% |
Return on Invested Capital (ROIC) | -36.69% | -26.47% | -33.23% | 15.06% | 106.34% | 195.58% |
Return on Capital Employed (ROCE) | -9.90% | -6.40% | -6.40% | 4.60% | 58.60% | 120.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -6.72% | -5.83% | -2.52% | 4.10% | 27.62% | 18.80% |
FCF Yield | 1.87% | 1.44% | -0.30% | 22.56% | 38.78% | 1.39% |
Buyback Yield / Dilution | -3.00% | -0.54% | 0.95% | 2.84% | 3.81% | -4.51% |